Its useful in situations like this, where prior studies are small because averaging the results of multiple small studies can remove some of the vicissitudes of chance that occasionally drive results in individual studies
Hardan AY, Fung LK, Libove RA, Obukhanych TV, Nair S, Herzenberg LA, et al
Importantly, using GLP1 medications to support PCOS management should not replace other evidence-based treatments
This means it may be suitable for short, single-session laboratory preparation, but it is not ideal when the vial will be accessed repeatedly
2 New drugs are likely to translate to replacement spend, rather than incremental savings, at least in the short term